Companion Diagnostic Tests in Oncology Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: C01CBDEFE3B8EN
Market Monitor Global

Abstracts

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

This report contains market size and forecasts of Companion Diagnostic Tests in Oncology in Global, including the following market information:

Global Companion Diagnostic Tests in Oncology Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Companion Diagnostic Tests in Oncology market was valued at 4012 million in 2021 and is projected to reach US$ 7377.3 million by 2028, at a CAGR of 9.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Protein Detection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Companion Diagnostic Tests in Oncology include Abbott, Roche, Genomic Health, QIAGEN, Agilent, Agendia, BioMerieux, Illumina and Siemens Healthcare and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Diagnostic Tests in Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Companion Diagnostic Tests in Oncology Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Companion Diagnostic Tests in Oncology Market Segment Percentages, by Type, 2021 (%)

• Protein Detection
• DNA Detection

Global Companion Diagnostic Tests in Oncology Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Companion Diagnostic Tests in Oncology Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Research Institutes
• Others

Global Companion Diagnostic Tests in Oncology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Companion Diagnostic Tests in Oncology Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Companion Diagnostic Tests in Oncology revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Companion Diagnostic Tests in Oncology revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Roche
• Genomic Health
• QIAGEN
• Agilent
• Agendia
• BioMerieux
• Illumina
• Siemens Healthcare
• Thermo Fisher

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Companion Diagnostic Tests in Oncology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Companion Diagnostic Tests in Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COMPANION DIAGNOSTIC TESTS IN ONCOLOGY OVERALL MARKET SIZE

2.1 Global Companion Diagnostic Tests in Oncology Market Size: 2021 VS 2028
2.2 Global Companion Diagnostic Tests in Oncology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Companion Diagnostic Tests in Oncology Players in Global Market
3.2 Top Global Companion Diagnostic Tests in Oncology Companies Ranked by Revenue
3.3 Global Companion Diagnostic Tests in Oncology Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostic Tests in Oncology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Companion Diagnostic Tests in Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Players in Global Market
  3.6.1 List of Global Tier 1 Companion Diagnostic Tests in Oncology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Companion Diagnostic Tests in Oncology Market Size Markets, 2021 & 2028
  4.1.2 Protein Detection
  4.1.3 DNA Detection
4.2 By Type - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
  4.2.1 By Type - Global Companion Diagnostic Tests in Oncology Revenue, 2017-2022
  4.2.2 By Type - Global Companion Diagnostic Tests in Oncology Revenue, 2023-2028
  4.2.3 By Type - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Companion Diagnostic Tests in Oncology Market Size, 2021 & 2028
  5.1.2 Pharmaceutical & Biotechnology Companies
  5.1.3 Medical Device Companies
  5.1.4 Research Institutes
  5.1.5 Others
5.2 By Application - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
  5.2.1 By Application - Global Companion Diagnostic Tests in Oncology Revenue, 2017-2022
  5.2.2 By Application - Global Companion Diagnostic Tests in Oncology Revenue, 2023-2028
  5.2.3 By Application - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Companion Diagnostic Tests in Oncology Market Size, 2021 & 2028
6.2 By Region - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
  6.2.1 By Region - Global Companion Diagnostic Tests in Oncology Revenue, 2017-2022
  6.2.2 By Region - Global Companion Diagnostic Tests in Oncology Revenue, 2023-2028
  6.2.3 By Region - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Companion Diagnostic Tests in Oncology Revenue, 2017-2028
  6.3.2 US Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.3.3 Canada Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.3.4 Mexico Companion Diagnostic Tests in Oncology Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Companion Diagnostic Tests in Oncology Revenue, 2017-2028
  6.4.2 Germany Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.4.3 France Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.4.4 U.K. Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.4.5 Italy Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.4.6 Russia Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.4.7 Nordic Countries Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.4.8 Benelux Companion Diagnostic Tests in Oncology Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Companion Diagnostic Tests in Oncology Revenue, 2017-2028
  6.5.2 China Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.5.3 Japan Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.5.4 South Korea Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.5.5 Southeast Asia Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.5.6 India Companion Diagnostic Tests in Oncology Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Companion Diagnostic Tests in Oncology Revenue, 2017-2028
  6.6.2 Brazil Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.6.3 Argentina Companion Diagnostic Tests in Oncology Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue, 2017-2028
  6.7.2 Turkey Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.7.3 Israel Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.7.4 Saudi Arabia Companion Diagnostic Tests in Oncology Market Size, 2017-2028
  6.7.5 UAE Companion Diagnostic Tests in Oncology Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Companion Diagnostic Tests in Oncology Major Product Offerings
  7.1.4 Abbott Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Companion Diagnostic Tests in Oncology Major Product Offerings
  7.2.4 Roche Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 Genomic Health
  7.3.1 Genomic Health Corporate Summary
  7.3.2 Genomic Health Business Overview
  7.3.3 Genomic Health Companion Diagnostic Tests in Oncology Major Product Offerings
  7.3.4 Genomic Health Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.3.5 Genomic Health Key News
7.4 QIAGEN
  7.4.1 QIAGEN Corporate Summary
  7.4.2 QIAGEN Business Overview
  7.4.3 QIAGEN Companion Diagnostic Tests in Oncology Major Product Offerings
  7.4.4 QIAGEN Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.4.5 QIAGEN Key News
7.5 Agilent
  7.5.1 Agilent Corporate Summary
  7.5.2 Agilent Business Overview
  7.5.3 Agilent Companion Diagnostic Tests in Oncology Major Product Offerings
  7.5.4 Agilent Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.5.5 Agilent Key News
7.6 Agendia
  7.6.1 Agendia Corporate Summary
  7.6.2 Agendia Business Overview
  7.6.3 Agendia Companion Diagnostic Tests in Oncology Major Product Offerings
  7.6.4 Agendia Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.6.5 Agendia Key News
7.7 BioMerieux
  7.7.1 BioMerieux Corporate Summary
  7.7.2 BioMerieux Business Overview
  7.7.3 BioMerieux Companion Diagnostic Tests in Oncology Major Product Offerings
  7.7.4 BioMerieux Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.7.5 BioMerieux Key News
7.8 Illumina
  7.8.1 Illumina Corporate Summary
  7.8.2 Illumina Business Overview
  7.8.3 Illumina Companion Diagnostic Tests in Oncology Major Product Offerings
  7.8.4 Illumina Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.8.5 Illumina Key News
7.9 Siemens Healthcare
  7.9.1 Siemens Healthcare Corporate Summary
  7.9.2 Siemens Healthcare Business Overview
  7.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Major Product Offerings
  7.9.4 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.9.5 Siemens Healthcare Key News
7.10 Thermo Fisher
  7.10.1 Thermo Fisher Corporate Summary
  7.10.2 Thermo Fisher Business Overview
  7.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Major Product Offerings
  7.10.4 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue in Global Market (2017-2022)
  7.10.5 Thermo Fisher Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Companion Diagnostic Tests in Oncology Market Opportunities & Trends in Global Market
Table 2. Companion Diagnostic Tests in Oncology Market Drivers in Global Market
Table 3. Companion Diagnostic Tests in Oncology Market Restraints in Global Market
Table 4. Key Players of Companion Diagnostic Tests in Oncology in Global Market
Table 5. Top Companion Diagnostic Tests in Oncology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Companion Diagnostic Tests in Oncology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Companion Diagnostic Tests in Oncology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Companion Diagnostic Tests in Oncology Product Type
Table 9. List of Global Tier 1 Companion Diagnostic Tests in Oncology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Companion Diagnostic Tests in Oncology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Companion Diagnostic Tests in Oncology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Companion Diagnostic Tests in Oncology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Companion Diagnostic Tests in Oncology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Companion Diagnostic Tests in Oncology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Companion Diagnostic Tests in Oncology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Companion Diagnostic Tests in Oncology Product Offerings
Table 32. Abbott Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Companion Diagnostic Tests in Oncology Product Offerings
Table 35. Roche Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 36. Genomic Health Corporate Summary
Table 37. Genomic Health Companion Diagnostic Tests in Oncology Product Offerings
Table 38. Genomic Health Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 39. QIAGEN Corporate Summary
Table 40. QIAGEN Companion Diagnostic Tests in Oncology Product Offerings
Table 41. QIAGEN Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 42. Agilent Corporate Summary
Table 43. Agilent Companion Diagnostic Tests in Oncology Product Offerings
Table 44. Agilent Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 45. Agendia Corporate Summary
Table 46. Agendia Companion Diagnostic Tests in Oncology Product Offerings
Table 47. Agendia Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 48. BioMerieux Corporate Summary
Table 49. BioMerieux Companion Diagnostic Tests in Oncology Product Offerings
Table 50. BioMerieux Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 51. Illumina Corporate Summary
Table 52. Illumina Companion Diagnostic Tests in Oncology Product Offerings
Table 53. Illumina Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 54. Siemens Healthcare Corporate Summary
Table 55. Siemens Healthcare Companion Diagnostic Tests in Oncology Product Offerings
Table 56. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)
Table 57. Thermo Fisher Corporate Summary
Table 58. Thermo Fisher Companion Diagnostic Tests in Oncology Product Offerings
Table 59. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Companion Diagnostic Tests in Oncology Segment by Type in 2021
Figure 2. Companion Diagnostic Tests in Oncology Segment by Application in 2021
Figure 3. Global Companion Diagnostic Tests in Oncology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Companion Diagnostic Tests in Oncology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Companion Diagnostic Tests in Oncology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2021
Figure 8. By Type - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
Figure 12. US Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
Figure 16. Germany Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 17. France Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
Figure 24. China Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 28. India Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
Figure 30. Brazil Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue Market Share, 2017-2028
Figure 33. Turkey Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Genomic Health Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. QIAGEN Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Agilent Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Agendia Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BioMerieux Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Illumina Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)